These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37184219)

  • 1. Polyneuropathy Associated with Age of Starting the Transfusion and Serum Ferritin Level in Iranian Patients with Thalassemia Major and Intermedia.
    Eghbali A; Ghaffari K; Shaykh Baygloo R; Eghbali A; Ghasemi A
    Hemoglobin; 2023 Nov; 47(2):42-48. PubMed ID: 37184219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Peripheral Neuropathy in Patients with β-Thalassemia via Electrophysiological Study: Reevaluation in the Era of Iron Chelators.
    Bayhan T; Ünal Ş; Konuşkan B; Erdem O; Karabulut E; Gümrük F
    Hemoglobin; 2018 Mar; 42(2):113-116. PubMed ID: 30200834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HFE Gene Mutations With Serum Ferritin Level and Heart and Liver Iron Overload in Patients With Transfusion-dependent Beta-Thalassemia.
    Zekavat OR; Zareian Jahromi M; Haghpanah S; Kargar Jahromi Z; Cohan N
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e26-e28. PubMed ID: 32925401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal sensorimotor neuropathy in patients with beta-thalassaemia.
    Stamboulis E; Vlachou N; Drossou-Servou M; Tsaftaridis P; Koutsis G; Katsaros N; Economou-Petersen E; Loutradi-Anagnostou A
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1483-6. PubMed ID: 15377704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalassemia Intermedia: Chelator or Not?
    Lee YC; Yen CT; Lee YL; Chen RJ
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyneuropathy Associated with Severe Iron Overload and Oxidative Stress in β-Thalassemia Patients.
    El-Tagui MH; Salama KM; El-Sabbagh MH; Youness ER; Ragaey M; Abdel-Salam A
    Indian J Hematol Blood Transfus; 2019 Jul; 35(3):518-522. PubMed ID: 31388267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
    Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of correlation between H63D and C282Y mutations in HFE gene and serum Ferritin level in beta-thalassemia major patients.
    Rahmani R; Naseri P; Safaroghli-Azar A; Tarighi S; Hosseini T; Hojjati MT
    Transfus Clin Biol; 2019 Nov; 26(4):249-252. PubMed ID: 31679808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral neuropathy in thalassaemia.
    Sawaya RA; Zahed L; Taher A
    Ann Saudi Med; 2006; 26(5):358-63. PubMed ID: 17019100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular abnormalities in multi-transfused beta-thalassemia patients.
    Jafari R; Heydarian S; Karami H; Shektaei MM; Dailami KN; Amiri AA; Rezaee MR; Far AA
    Indian J Ophthalmol; 2015 Sep; 63(9):710-5. PubMed ID: 26632126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
    Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
    Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of serum ferritin levels with hepatic MRI T2 and liver iron concentration in nontransfusion beta-thalassemia intermediate patients: A contemporary issue.
    Karimi M; Amirmoezi F; Haghpanah S; Ostad S; Lotfi M; Sefidbakht S; Rezaian S
    Pediatr Hematol Oncol; 2017 Aug; 34(5):292-297. PubMed ID: 29190176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary iron excretion for evaluating iron chelation efficacy in children with thalassemia major.
    Wahidiyat PA; Wijaya E; Soedjatmiko S; Timan IS; Berdoukas V; Yosia M
    Blood Cells Mol Dis; 2019 Jul; 77():67-71. PubMed ID: 30978615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia.
    Karimi M; Arandi N; Haghpanah S; Ansari S; Azarkeyvan A; Bordbar M; Safaei S
    Hemoglobin; 2015; 39(5):327-9. PubMed ID: 26114738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study.
    Musallam KM; Cappellini MD; Daar S; Karimi M; El-Beshlawy A; Graziadei G; Magestro M; Wulff J; Pietri G; Taher AT
    Haematologica; 2014 Nov; 99(11):e218-21. PubMed ID: 24997148
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of diastolic function in children with transfusion dependent beta thalassemia major by tissue and conventional doppler imaging indices and its correlation with serum ferritin levels.
    Nanjegowda CK; Kamath SP; Kamath P; Shah TD; Kulkarni V; Lashkari HP; Baliga BS
    Turk J Pediatr; 2019; 61(2):250-256. PubMed ID: 31951335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cutoff of Ferritin for Evaluation of Hypothyroidism in Patients With Thalassemia.
    Baghersalimi A; Rad AH; Koohmanaee S; Darbandi B; Mirzaee MM; Aminzadeh V; Medghalchi A; Dalili S
    J Pediatr Hematol Oncol; 2019 Oct; 41(7):515-518. PubMed ID: 31008807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of iron overload and glomerular filtration rate estimated by cystatin C in patients with β-thalassemia major.
    Al-Khabori M; Bhandari S; Al-Rasadi K; Mevada S; Al-Dhuhli H; Al-Kemyani N; Daar S
    Hemoglobin; 2014; 38(5):365-8. PubMed ID: 25074643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.